APA

Khardori N. M., . (20120125). Biological response modifiers (BRMs) are often discussed with a narrow focus on the“biological therapies,” ie, the pharmacologically administered form of cytokines, eg, interferon or antagonists of cytokines, eg, tumor necrosis factor blocking agents. Introduction. : Infectious disease clinics of North America.

Chicago

Khardori Nancy Misri, . 20120125. Biological response modifiers (BRMs) are often discussed with a narrow focus on the“biological therapies,” ie, the pharmacologically administered form of cytokines, eg, interferon or antagonists of cytokines, eg, tumor necrosis factor blocking agents. Introduction. : Infectious disease clinics of North America.

Harvard

Khardori N. M., . (20120125). Biological response modifiers (BRMs) are often discussed with a narrow focus on the“biological therapies,” ie, the pharmacologically administered form of cytokines, eg, interferon or antagonists of cytokines, eg, tumor necrosis factor blocking agents. Introduction. : Infectious disease clinics of North America.

MLA

Khardori Nancy Misri, . Biological response modifiers (BRMs) are often discussed with a narrow focus on the“biological therapies,” ie, the pharmacologically administered form of cytokines, eg, interferon or antagonists of cytokines, eg, tumor necrosis factor blocking agents. Introduction. : Infectious disease clinics of North America. 20120125.